Group 1 - The 2025 stock ETF fund annual report reveals a significant performance, with the champion fund soaring by 233% during the year [1][3] - The overall industry scale is approaching a new high of 36 trillion yuan [1][3] - The worst-performing funds for the year include Penghua Wine ETF with a decline of 12.2%, Huaan Food and Beverage ETF down by 8.75%, and Yinhua Food ETF decreasing by 8.66% [1][3] Group 2 - Over the past three years, the vaccine ETFs have experienced substantial declines, with the Fuguo Vaccine ETF down by 37.96%, Guotai Vaccine ETF down by 37.68%, and Penghua Wine ETF down by 36.54% [2][4]

Core Insights - The 2025 stock ETF has shown a remarkable performance with a year-to-date increase of 233%, indicating a strong recovery in active equity investments [1][2] - The overall industry scale is approaching a new high of 36 trillion yuan, reflecting significant growth in the investment sector [1][2] Performance Summary - The 2025 stock ETF's performance from 2023 to 2025 has been officially released, highlighting the substantial gains in certain funds [1][2] - Specific ETFs such as the vaccine ETFs have experienced significant declines, with the 富国 vaccine ETF down by 37.96%, the 国泰 vaccine ETF down by 37.68%, and the 鹏华 wine ETF down by 36.54% over the same period [1][2]